Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Next Previous
X
Search
Trial Profile

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Aug 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oesophageal stem cell implant (Primary)
  • Indications Oesophageal cancer; Oesophageal disorders; Oesophageal perforation
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors Harvard Apparatus Regenerative Technology

    • Most Recent Events

    • 26 Aug 2024 According to a Harvard Apparatus Regenerative Technology media release, FDA has approved a ten-patient phase one and phase two clinical trial to study the repair of damage to the esophagus in adults caused by cancer or injury.
    • 13 Nov 2023 According to a Biostage media release, the company has activated the second clinical trial site with the University of Michigan in August 2023 to expand the screening of patients and actively recruiting clinical trial patients at both the Mayo Clinic and University of Michigan.
    • 18 Jul 2023 Status changed from not yet recruiting to recruiting, according to a Biostage media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top